These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3105461)

  • 1. [Studies on the new antibiotic kazusamycin and related substances].
    Umezawa I; Komiyama K
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):858-64. PubMed ID: 3105461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect of kazusamycin B on experimental tumors.
    Yoshida E; Komiyama K; Naito K; Watanabe Y; Takamiya K; Okura A; Funaishi K; Kawamura K; Funayama S; Umezawa I
    J Antibiot (Tokyo); 1987 Nov; 40(11):1596-604. PubMed ID: 3693127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new antitumor antibiotic, kazusamycin.
    Umezawa I; Komiyama K; Oka H; Okada K; Tomisaka S; Miyano T; Takano S
    J Antibiot (Tokyo); 1984 Jul; 37(7):706-11. PubMed ID: 6432763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kazusamycin B, a novel antitumor antibiotic.
    Funaishi K; Kawamura K; Sugiura Y; Nakahori N; Yoshida E; Okanishi M; Umezawa I; Funayama S; Komiyama K
    J Antibiot (Tokyo); 1987 Jun; 40(6):778-85. PubMed ID: 3610834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of a new antibiotic, kazusamycin.
    Komiyama K; Okada K; Hirokawa Y; Masuda K; Tomisaka S; Umezawa I
    J Antibiot (Tokyo); 1985 Feb; 38(2):224-9. PubMed ID: 3922935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K; Oka T; Morimoto M
    Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological activities of a new antitumor antibiotics].
    Umezawa I
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2674-80. PubMed ID: 6439122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
    Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
    Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of kazusamycin on the growth of murine solid tumors and their spontaneous metastasis.
    Yoshida E; Nishimuta Y; Naito K; Watanabe Y; Tomisaka S; Okura A; Komiyama K; Umezawa I
    J Antibiot (Tokyo); 1987 Mar; 40(3):391-3. PubMed ID: 3106290
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of kazusamycin B on the cell cycle and morphology of cultured L1210 cells.
    Takamiya K; Yoshida E; Takahashi T; Okura A; Okanishi M; Komiyama K; Umezawa I
    J Antibiot (Tokyo); 1988 Dec; 41(12):1854-61. PubMed ID: 3209477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural study of a new antitumor antibiotic, kazusamycin.
    Komiyama K; Okada K; Oka H; Tomisaka S; Miyano T; Funayama S; Umezawa I
    J Antibiot (Tokyo); 1985 Feb; 38(2):220-9. PubMed ID: 3922934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nature of the modifying action of polyunsaturated fatty acids on the growth of transplantable tumors of different types].
    Kudriavtsev IA; Alekseev SM; Ashirova VE; Evstigneeva RP; Miasishcheva NV
    Biull Eksp Biol Med; 1988 Apr; 105(4):471-4. PubMed ID: 3359034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effect of a new antibiotic, neothramycin.
    Hisamatsu T; Uchida S; Takeuchi T; Ishizuka M; Umezawa H
    Gan; 1980 Jun; 71(3):308-12. PubMed ID: 7418976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
    Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental study of the antitumor anthracycline antibiotic aclarubicin (aclacinomycin A)].
    Egorov LV; Terent'eva TG; Rudneva NA; Egorenko GG; Ivanitskaia LP
    Antibiot Med Biotekhnol; 1985 Dec; 30(12):918-27. PubMed ID: 3866512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties.
    Zou Y; Ling YH; Van NT; Priebe W; Perez-Soler R
    Cancer Res; 1994 Mar; 54(6):1479-84. PubMed ID: 8137251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice.
    Shimomura K; Manda T; Mukumoto S; Masuda K; Nakamura T; Mizota T; Matsumoto S; Nishigaki F; Oku T; Mori J
    Cancer Res; 1988 Mar; 48(5):1166-72. PubMed ID: 3342397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of mouse tumors with 7-con-O-methylnogarol and other analogs of the anthracycline antibiotic, nogalamycin.
    Neil GL; Kuentzel SL; McGovren JP
    Cancer Treat Rep; 1979; 63(11-12):1971-8. PubMed ID: 526931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-antitumor activity relationship of semi-synthetic spicamycin analogues.
    Kamishohara M; Kawai H; Odagawa A; Isoe T; Mochizuki J; Uchida T; Hayakawa Y; Seto H; Tsuruo T; Otake N
    J Antibiot (Tokyo); 1993 Sep; 46(9):1439-46. PubMed ID: 8226322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of leptomycin B.
    Komiyama K; Okada K; Tomisaka S; Umezawa I; Hamamoto T; Beppu T
    J Antibiot (Tokyo); 1985 Mar; 38(3):427-9. PubMed ID: 4008334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.